


ProGenis Pharmaceuticals
Pharmaceutical Manufacturing • Perth, Western Australia, Australia • 1-10 Employees
Company overview
| Headquarters | 3 Brodie-Hall Dr, Suite 7 & 10, Bentley, Western Australia 6102, AU |
| Phone number | +61894160921 |
| Website | |
| NAICS | 3254 |
| Keywords | Drug Development And Rna Therapeutics |
| Founded | 2021 |
| Employees | 1-10 |
Key Contact at ProGenis Pharmaceuticals
Rakesh Veedu
Co-Founder & Managing Director
ProGenis Pharmaceuticals Email Formats
ProGenis Pharmaceuticals uses 2 email formats. The most common is {first name} (e.g., john@progenispharma.com), used 71.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@progenispharma.com | 71.4% |
{first initial} | j@progenispharma.com | 28.6% |
About ProGenis Pharmaceuticals
ProGenis Pharmaceuticals is focused on developing next generation RNA therapeutics that are more efficient, safer and accessible to treat inherited rare and acquired diseases. ProGenis is headquartered in Perth, Australia, and led by world-renowned experts with significant experience in RNA therapeutics including antisense oligonucleotide chemistries and manufacturing.
ProGenis Pharmaceuticals revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $1,700,000 |
| Total funding | $239,200 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
ProGenis Pharmaceuticals has 2 employees across 2 departments.
Departments
Number of employees
ProGenis Pharmaceuticals Tech Stack
Discover the technologies and tools that power ProGenis Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Maps
WordPress themes
Page builders
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Programming languages
Blogs
Frequently asked questions
4.8
40,000 users



